1Monner L, Lapinski H, Colette C. Contribution of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetes variations with increasing levels of HbA1C. Diabetes care ,2003,26(3) :881
2Bonora E, Formentini G, Calcaterra F, et al. Plasma Glucose Levels Throughout the Day and HbA1C Interrelationships in Type 2 Diabetes: Implications for treatment and monitoring of metabolic control. Diabetes care,2001,24(12) :2023
3Hillman N,Herranz L, Grande C, et al. Is HbA1C Influenced More Strongly by Preprandial or Postprandial Glycemia in Type 1 Diabetes?. Diabetes Care ,2002,25(6): 1100
4Bastyr EJ, Stuart CA, Brodows RG, et al. Therapy focused on lowering postprandial glucose,not fasting glucose,may be superior for lowering HbA1C. Diabetes Care ,2000,23(9): 1236
5Rohlfing CL,England JD,Wiedmeyer HM, et al. Defining the relationship between plasma glucose and HbA1C analysis of glucose profiles and HbA1C in the diabetes control and complications trial. Diabetes Care ,2002,25 (2) :275
6Hillman N, Herranz L, Grande C, et al. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes? Diabet Med ,2004,21(5) :468
7UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33). Lancet, 1998,352(9131 ):837
8The DECODE study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 1999,354(9179): 617
9Giugliano D, Marfella R, Coppola L, et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation, 1997,95 (7): 1783
10Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilatation in humans in vivo.Circulation, 1998,97 ( 17 ): 1695
